Lyra Therapeutics Inc (LYRA) earnings · rev $398.0K
These earnings events as JSON? API free 100/dayLyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
This LYRA earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported LYRA revenue for 2025-12-31 was $398.0K. Net income was -$28.9M. Revenue was down 74.1% from 2024-12-31 to 2025-12-31. LYRA currently screens at market cap $14.4M.
When the next LYRA 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 74.1% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full LYRA research stays on the stock page; the tape stays on the quote page.
LYRA earnings FAQ
What are LYRA's latest revenue and net income?
Latest cached Lyra Therapeutics Inc (LYRA) revenue for Dec 31, 2025 was $398.0K. Net income was -$28.9M. Statements: https://lician.com/financials/lyra
What is LYRA's latest diluted EPS?
Latest cached Lyra Therapeutics Inc (LYRA) diluted EPS for Dec 31, 2025 was -$18.62.
What period does the latest LYRA earnings print cover?
The latest cached Lyra Therapeutics Inc (LYRA) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did LYRA revenue change from the prior cached period?
Cached Lyra Therapeutics Inc (LYRA) revenue was down 74.1% from $1.5M (Dec 31, 2024) to $398.0K (Dec 31, 2025). Statements: https://lician.com/financials/lyra
Where are LYRA earnings listed?
Cached earnings facts for Lyra Therapeutics Inc (LYRA) are listed at https://lician.com/earnings/lyra. Statements: https://lician.com/financials/lyra
Not investment advice.